[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Axsome Therapeutics, Inc (AXSM)
Axsome Therapeutics (AXSM) is up XXX% today due to positive SYMBRAVO data and analyst ratings. The company is hosting a Frontiers in Brain Health R&D Day on July 21st.
About Axsome Therapeutics, Inc
Axsome Therapeutics, Inc. (AXSM) is a healthcare company focused on developing and commercializing novel therapies for central nervous system (CNS) disorders.
Axsome Therapeutics, Inc uses the ticker $AXSM for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Axsome Therapeutics, Inc (AXSM) creators is up XXXXXX% from the previous month.
- Axsome Therapeutics, Inc (AXSM) engagements is up XXXXX% from the previous week.
- Axsome Therapeutics, Inc (AXSM) mentions is up XXXXXX% from the previous month.
- Axsome Therapeutics, Inc (AXSM) posts created is up XXXXXX% from the previous month.
Price: $XXX #
Price 24-Hour Chart Data
The price increase of XXX% today appears to be driven by positive news regarding SYMBRAVO data and the recent Morgan Stanley coverage with an Overweight rating, despite a decrease in social mentions.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXX% | -XXXX% | XXXX% |
1-Year High: $XXXXXX on 2025-02-21
1-Year Low: $XXXXX on 2025-01-10
AltRank: XXXXX #
AltRank 24-Hour Chart Data
Axsome Therapeutics, Inc (AXSM) is currently AltRank #1,625 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +886
1 Month: XXXXX +1,038
6 Months: XXXXX +1,334
1 Year: XXXXX +1,029
1-Year High: XXXXX on 2024-10-27
1-Year Low: X on 2025-03-02
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-06-23
1-Year Low: X on 2024-10-30
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX +49%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +17%
1 Year: XXXXXXXXXX +54%
1-Year High: XXXXXXX on 2025-02-19
1-Year Low: XXX on 2025-03-30
| Social Network | X | |
|---|---|---|
| Engagements | XXXXX | X |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +78%
1 Month: XXXXX +211%
6 Months: XXXXX +28%
1 Year: XXXXX +139%
1-Year High: XXX on 2025-01-02
1-Year Low: XX on 2024-09-29
| Social Network | X | |
|---|---|---|
| Mentions | XXX | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Axsome Therapeutics, Inc (AXSM) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX +44%
1 Month: XXX +501%
6 Months: XXXXX +65%
1 Year: XXXXX +228%
1-Year High: XXX on 2025-01-02
1-Year Low: XX on 2024-09-29
The most influential creators that mention Axsome Therapeutics, Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Andre_AGTC | X | XXXXX | X | XXXXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +17%
6 Months: XX% +18%
1 Year: XX% -X%
1-Year High: XXX% on 2024-07-27
1-Year Low: XX% on 2024-12-22
Most Supportive Themes
- Analyst Target Price: (15%) Analysts are reiterating high target prices for AXSM, boosting investor confidence.
- Positive Sentiment: (12%) A large percentage of social media sentiment is positive regarding AXSM.
- Revenue and Growth Potential: (11%) Recent financial results show revenue growth, and expectations of expanding the drug portfolio.
Most Critical Themes
- Decreased Mentions: (2%) Mentions of Axsome Therapeutics, Inc. have decreased on social media.
- Decreased Engagement: (2.55%) Weekly interactions are down, which could signal waning engagement.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XX | X% |
| X | X% | X | X% | X | X% | |
| Total | XXXXX | XX% | XXXXX | XX% | XX | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-07-15
Market Dominance: XXXXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-07
1-Year Low: XXXXXXX% on 2025-07-24
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$6%
1 Month: $XXXXXXXXXXXXX +$0.64%
6 Months: $XXXXXXXXXXXXX +$5.50%
1 Year: $XXXXXXXXXXXXX +$28%
1-Year High: $XXXXXXXXXXXXX on 2025-02-21
1-Year Low: $XXXXXXXXXXXXX on 2025-01-10
Top assets mentioned In the posts about Axsome Therapeutics, Inc in the last XX hours
Bitcoin Incognito (XBI) Neurocrine Biosciences, Inc. (NBIX) Biogen Inc (BIIB) Blueprint Medicines Corporation (BPMC) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Alnylam Pharmaceuticals, Inc. (ALNY) Intra-Cellular Therapies Inc. (ITCI) Akropolis (AKRO) SuperRare (RARE)
Top topics mentioned In the posts about Axsome Therapeutics, Inc in the last XX hours
gme, pltr, meta, $asnd, nio, nvda, $vrna, $xbi, $nbix, cort, $biib, $ixhl, $fsm, mia, vrtx, $cnta, $mirm, $bpmc, $qntm, $veon, manat, $mrns, $mdgl, qqq, spx, $zlab, $argx, $alny, $knsa, $tnxp, $itci, telo, $akro, $lyel, $rare, op, amgn, pfe, $bbio, $srpt, $cmrx, $tak, nasdaq, $imcr, stocks, $legn, $futu, simpson, $thrd, $vrdn, dawn, $swtx, pdsb, $cdtx, $xfor, evgo, alzheimers, mi, reta, $mtrx, $prvb, $tptx, quarterly earnings, $vktx, $avxl, tars, $tars, $mlys, hims, $cere, $insm, $hrmy, allk, onon, $ziop, veru, biogen inc, tak, $lly, $nvct, eli lilly, stocks healthcare, $abeo, trx, spy, $urgn, flr, stocks financial services, $flks, $2353tw, acer, $vcnx, investment, $prme, $allk, $dawn, $gcbc, $lgps, $drrx, $reg
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$RYTM $VRNA $AES $BE $NEGG $CRNX $LGND $GRFS $SRRK $WGS $CYTK $RARE $TLX $TNXP $AG $SMMT $XENE $RNA $KNSA $FUTU $KYMR $APLS $TGTX $BBIO $AGIO $AXSM $SLNO $CRSP $ASND $FSM $PCVX $LYEL $ORLA $MDGL $ARWR $ROIV"
@linhnguyen64143 on X 2025-07-24 00:04:22 UTC XX followers, X engagements
"$AXSM: Axsome Therapeutics is transforming the CNS biotech landscape with rapid revenue growth and a pipeline targeting multi-billion-dollar markets. Auvelitys uptake is fueling momentum while Symbravo and new indications could drive a major expansion. Analysts see 46%+ revenue CAGR and a path to profitability. Is this the next breakout CNS franchise"
@SentinelFlash on X 2025-07-24 00:00:31 UTC XX followers, XXX engagements
"$NVCT delayed data NXP800 ongoing. Opposite universal low expectations Im expecting major rising stock price with data release showing tumor shrinkage 75mg intermittent dosing. Sets up free-roll on NXP900 a drug many investors think has blockbuster potential $AXSM $LLY $MRK $PFE"
@DalvinVarnado on X 2025-07-23 14:39:36 UTC 27.8K followers, 1094 engagements
"Biggest Losers: $BMI $LMT $THC $MCRB $MSCI $PM $EFX $GM $ACHR $STEM $AXSM $LGND $SITM $FRHC $KTOS $IONQ $VICR $MGNI $ONON $MDGL $TTMI"
@FrenzyCapital on X 2025-07-23 11:58:09 UTC 1572 followers, XXX engagements